Clovis Oncology (CLVS) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 118 253 sessions, December 20, 2021 to December 20, 2022
- Largest daily move
- -71.6% close of November 9, 2022
- 1-year change
- -97.5% closing prices, December 20, 2021 to December 20, 2022
- 1-month change
- -76.7% closing prices, November 18, 2022 to December 20, 2022
Company Description
Clovis Oncology (Nasdaq: CLVS) is classified in the biotechnology industry within the Healthcare sector.
CLVS has declined 97.5% over the past year. The last closing price was $0.0812.
This page collects what Stock Titan holds for CLVS, including price data and latest news.
Stock Performance
Clovis Oncology (CLVS) closed at $0.0812 on December 20, 2022. Over the past 12 months, the price has lost 97.5%.
CLVS Metrics & Rankings
Price returns through December 20, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Clovis Oncology has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, earnings, conferences. View all CLVS news →
SEC Filings
CLVS Company Profile & Sector Positioning
Clovis Oncology (CLVS) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing CLVS often look at related companies in the same sector, including XTL Biopharmaceuticals Ltd. (XTLB), Soligenix, Inc. (SNGX), Leap Therapeutics, Inc. (LPTX), Sensei Biotherapeutics, Inc. (SNSE), and Moleculin Biotech, Inc. (MBRX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLVS's relative position within its industry.